After treat-to-target: can a targeted ultrasound initiative improve RA outcomes?

Annals of the Rheumatic Diseases
Richard J WakefieldPaul Emery

Abstract

For patients with rheumatoid arthritis (RA), remission can be achieved with tight control of inflammation and early use of disease modifying agents. The importance of remission as an outcome has been recently highlighted by European League Against Rheumatism recommendations. However, remission when defined by clinical remission criteria (disease activity score, simplified disease activity index, etc) does not always equate to the complete absence of inflammation as measured by new sensitive imaging techniques such as ultrasound (US) . There is evidence that imaging synovitis is frequently found in these patients and associated with adverse clinical and functional outcomes. This article reviews the data regarding remission, ultrasound imaging and outcomes in patients with RA to provide the background to a consensus statement from an international collaboration of ultrasonographers and rheumatologists who have recently formed a research network--the Targeted Ultrasound Initiative (TUI) group. The statement proposes that targeting therapy to PD activity provides superior outcomes compared with treating to clinical targets alone and introduces the rationale for a new randomised trial using targeted ultrasound in RA.

Citations

May 24, 2013·Clinical Rheumatology·Rafael Mendonça da Silva ChakrJoão Carlos Tavares Brenol
Nov 10, 2013·La Revue de médecine interne·T LequerréO Vittecoq
May 22, 2013·Nature Reviews. Rheumatology·Sarah Ohrndorf, Marina Backhaus
Dec 12, 2012·Rheumatology·Rainer Klocke
Sep 21, 2013·Rheumatology·Jun FukaeTakao Koike
Apr 10, 2014·Arthritis Research & Therapy·Kei IkedaHiroshi Nakajima
Sep 28, 2013·Rheumatology International·Christina DuftnerChristian Dejaco
Jun 7, 2013·Annals of the Rheumatic Diseases·Rusmir HusicChristian Dejaco
May 15, 2015·Annals of the Rheumatic Diseases·Josef S SmolenDesirée van der Heijde
Dec 25, 2015·Best Practice & Research. Clinical Rheumatology·Joshua F BakerPhilip G Conaghan
Aug 5, 2015·Rheumatology International·Antonio NaranjoCarlos Rodríguez-Lozano
Oct 30, 2014·International Journal of Rheumatic Diseases·Taeyoung KangPaul Emery
Sep 16, 2014·Diagnostic and Interventional Imaging·K Ben AbdelghaniL Zakraoui
Jun 19, 2015·Annals of the Rheumatic Diseases·Anna-Birgitte AgaEspen A Haavardsholm
Dec 13, 2016·Annals of the Rheumatic Diseases·M A D'AgostinoP G Conaghan
Feb 17, 2017·International Journal of Rheumatic Diseases·Fredrick JoshuaPeter Wong
Mar 2, 2017·Alimentary Pharmacology & Therapeutics·P B AllenL Peyrin-Biroulet
Mar 5, 2017·BMC Musculoskeletal Disorders·Hakim LazaarMartin Soubrier
Jan 15, 2015·British Journal of Hospital Medicine·A Mian, D L Scott
Oct 13, 2018·Genetic Epidemiology·Svetlana CherlinHeather J Cordell
Feb 6, 2019·JAMA : the Journal of the American Medical Association·Daniel Aletaha, Josef S Smolen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.